Publication | Open Access
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
59
Citations
17
References
2017
Year
NACCRT does not prolong DFS and OS in localized or locally advanced perihilar CCA. However, NACCRT may allow tumor downstaging and improve tumor resectability.
| Year | Citations | |
|---|---|---|
Page 1
Page 1